Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia

Janssen COVID-19 Vaccine was authorized for use in Canada on March 5, 2021 in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 . Since the time of authorization, there have been very rare reports of thrombosis with thrombocytopenia following administration of Janssen COVID-19 Vaccine.

COVID